What are Mission Vision & Core Values of BICO Company?

The primary audience for BICO's technologies and solutions is the pharmaceutical and biopharma industries. This targeted approach allows BICO to tailor its offerings to the specific needs and challenges of these sectors. This strategic focus helps BICO refine its product development and market strategies, ensuring alignment with industry demands.

BICO's core offering revolves around providing technologies and solutions that accelerate drug development, enhance safety and specificity, and reduce reliance on animal testing. This value proposition is particularly compelling given the increasing regulatory pressures and ethical considerations surrounding animal testing. The company aims to provide solutions that are both technologically advanced and ethically sound.

The mission statement underscores BICO's commitment to innovation and customer-centricity. By focusing on solving critical challenges faced by its target market, BICO positions itself as a key partner in the advancement of drug discovery and development. This approach fosters strong relationships with clients and drives continuous improvement in its product offerings.

BICO's laboratory automation technologies are designed to streamline workflows in drug discovery and development. This includes solutions like bioprinting, which creates 3D human tissue models, directly contributing to reducing the need for animal testing. The company's focus on accessible life science solutions that combine biology and technology underscores its unique value proposition in the bioconvergence field.

The BICO goals are centered around accelerating the development of new treatments. This includes a focus on improving the efficiency and safety of drug development processes. By reducing the need for animal testing, BICO aims to not only improve ethical standards but also to potentially reduce the time and costs associated with bringing new drugs to market. BICO's mission is clearly aligned with the broader goals of the pharmaceutical industry.

The BICO company mission statement is highly relevant in today's market. The global pharmaceutical market is expected to reach $1.48 trillion by 2027, according to a report by Fortune Business Insights. This growth is fueled by the increasing demand for innovative treatments and the need for more efficient drug development processes. BICO's focus on providing solutions that address these needs positions it well for future growth. To learn more about their target market, you can read about the Target Market of BICO.

The vision statement is inherently future-oriented, emphasizing a commitment to innovation. This focus is essential in a rapidly evolving field like life sciences, where technological advancements are constantly reshaping research and development.

The vision highlights automation as a key component. Automating lab processes can significantly increase efficiency, reduce human error, and accelerate the pace of scientific discovery. This aligns with the growing demand for high-throughput screening methods.

The vision's broad scope, encompassing the entire life science lab, suggests a holistic approach. This comprehensive vision aims to impact the entire research and development pipeline, from initial discovery to therapeutic development.

BICO's vision is supported by its focus on cutting-edge technologies. Robotics, AI, advanced genomics, and 3D bioprinting are all critical components of the life science lab of the future. The company is investing heavily in these areas.

The vision implies a commitment to market leadership. BICO aims to be at the forefront of technological advancements in the life sciences. This requires continuous innovation and a strong focus on research and development.

The vision aligns with the increasing demand for personalized medicine and advanced cell culture methods. The life sciences industry is moving towards more sophisticated and efficient research approaches, which BICO is positioned to support. For instance, the global 3D bioprinting market is projected to reach $3.5 billion by 2027, showcasing the potential of BICO's technology. (Source: Market Research Future)

A key strategic decision guided by the BICO mission and vision was the divestment of non-core assets. In April 2025, BICO announced the sale of MatTek and Visikol for $80 million. This move allowed BICO to concentrate on its core strengths in lab automation and selected workflows. This strategic realignment is expected to yield a positive net cash position in Q2 2025, providing the financial flexibility to pursue growth initiatives aligned with its mission.

BICO's commitment to its BICO goals is further demonstrated through its continued investment in research and development. The company is focused on combining biology and technology, particularly in bioprinting and lab automation solutions. These investments directly support the BICO mission of accelerating and improving drug development and realizing its vision of automating the life science lab.

While it can be challenging to directly link specific metrics to mission and vision statements, BICO's Q1 2025 report provides some insight. The Bioprinting segment experienced a robust organic growth of 41%, indicating positive progress in an area central to its core technologies and mission. This growth suggests that BICO's focus on bioprinting is delivering tangible results, supporting its strategic direction.

Leadership's dedication to the updated strategy and vision is clear. Maria Forss, President and CEO, emphasized the significance of BICO 2.0 in enabling and automating the life science lab of the future. This commitment from the top underscores the importance of the BICO values in guiding the company's actions and future direction.

The strategic decisions driven by BICO's mission and vision have a tangible impact on its financial performance. The divestment of non-core assets is expected to improve the company's financial position. Furthermore, the strong growth in the Bioprinting segment signals the potential for increased revenue and profitability in alignment with its BICO company mission statement.

By concentrating on bioconvergence and lab automation, BICO is strategically positioning itself in a rapidly growing market. This focus allows the company to leverage its core competencies and build a competitive advantage. For a better understanding of the competitive landscape, you can explore the Competitors Landscape of BICO.

Leadership plays a vital role in reinforcing BICO's mission, vision, and core values. This is achieved through consistent communication and strategic events.

For instance, the Capital Markets Day in September 2024 was a key event for communicating the updated strategy, vision, and mission to stakeholders. This ensures that investors, employees, and the public understand BICO's direction and values.

Effective communication is crucial for ensuring that employees understand and embrace BICO's mission, vision, and values. This is facilitated through various internal policies and the BICO Group Code of Conduct.

The BICO Group Code of Conduct and internal policies help ensure that all employees understand and are aligned with the company's principles. This creates a cohesive and values-driven work environment.

BICO's commitment to its core values is evident in its actions. This includes investments in research and development (R&D) and sustainable practices.

Concrete examples of alignment between stated values and actual business practices include their investments in R&D for innovative bioconvergence technologies and their commitment to sustainable operations and reducing animal testing. For example, BICO invested approximately $30 million in R&D in the last fiscal year, demonstrating its commitment to innovation. Additionally, the company's focus on sustainable operations, including initiatives to reduce its environmental impact, aligns with its core values. Learn more about BICO's marketing approach in our article on Marketing Strategy of BICO.

While specific formal programs are not extensively detailed, BICO appears to have a structured approach to embedding its principles within the organization. This includes performance management and a global HR strategy.

The emphasis on a performance management process and a global HR strategy that incorporates corporate values suggests a structured approach to embedding these principles within the organization. This helps ensure that employees are evaluated and rewarded based on their alignment with BICO's mission, vision, and core values.